Medtronic (MDT)
(Delayed Data from NYSE)
$79.74 USD
+0.49 (0.62%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $79.98 +0.24 (0.30%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Medtronic PLC falls in the month of April.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 | 4/30/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 3,784.00 | 5,062.00 | 3,630.00 | 4,806.00 | 4,650.00 |
Depreciation/Amortization & Depletion | 2,697.00 | 2,707.00 | 2,702.00 | 2,663.00 | 2,659.00 |
Net Change from Assets/Liabilities | -967.00 | -889.00 | -701.00 | 61.00 | -1,080.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 525.00 | 466.00 | 609.00 | -296.00 | 778.00 |
Net Cash From Operating Activities | 6,039.00 | 7,346.00 | 6,240.00 | 7,234.00 | 7,007.00 |
Property & Equipment | -1,459.00 | -1,368.00 | -1,355.00 | -1,213.00 | -1,134.00 |
Acquisition/ Disposition of Subsidiaries | -1,867.00 | -91.00 | -994.00 | -488.00 | -1,827.00 |
Investments | -171.00 | -190.00 | -463.00 | -1,465.00 | 2,151.00 |
Other Investing Activities | 4.00 | -10.00 | -54.00 | -37.00 | 36.00 |
Net Cash from Investing Activities | -3,493.00 | -1,659.00 | -2,866.00 | -3,203.00 | -774.00 |
Uses of Funds
4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 | 4/30/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -337.00 | -2,115.00 | -178.00 | -664.00 | -1,885.00 |
Issuance (Repayment) of Debt | -603.00 | -1.00 | -195.00 | -542.00 | -154.00 |
Increase (Decrease) Short-Term Debt | 5.00 | 0.00 | -375.00 | -17.00 | -713.00 |
Payment of Dividends & Other Distributions | -3,616.00 | -3,383.00 | -3,120.00 | -2,894.00 | -2,693.00 |
Other Financing Activities | -409.00 | 163.00 | -268.00 | -81.00 | 14.00 |
Net Cash from Financing Activities | -4,960.00 | -5,336.00 | -4,136.00 | -4,198.00 | -5,431.00 |
Effect of Exchange Rate Changes | 243.00 | -231.00 | 215.00 | -86.00 | -78.00 |
Net Change In Cash & Equivalents | -2,171.00 | 121.00 | -547.00 | -253.00 | 724.00 |
Cash at Beginning of Period | 3,714.00 | 3,593.00 | 4,140.00 | 4,393.00 | 3,669.00 |
Cash at End of Period | 1,543.00 | 3,714.00 | 3,593.00 | 4,140.00 | 4,393.00 |
Diluted Net EPS | 2.82 | 3.73 | 2.66 | 3.54 | 3.41 |
Fiscal Year End for Medtronic PLC falls in the month of April.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | 1/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 3,045.00 | 1,708.00 | 797.00 | 3,784.00 | 2,595.00 |
Depreciation/Amortization & Depletion | 1,993.00 | 1,344.00 | 672.00 | 2,697.00 | 2,018.00 |
Net Change from Assets/Liabilities | -1,408.00 | -1,918.00 | -823.00 | -967.00 | -1,525.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 380.00 | 402.00 | 229.00 | 525.00 | 491.00 |
Net Cash From Operating Activities | 4,010.00 | 1,536.00 | 875.00 | 6,039.00 | 3,579.00 |
Property & Equipment | -1,161.00 | -815.00 | -354.00 | -1,459.00 | -1,081.00 |
Acquisition/ Disposition of Subsidiaries | -74.00 | -22.00 | 0.00 | -1,867.00 | -1,867.00 |
Investments | -280.00 | -67.00 | -168.00 | -171.00 | -85.00 |
Other Investing Activities | -155.00 | -59.00 | -17.00 | 4.00 | 15.00 |
Net Cash from Investing Activities | -1,670.00 | -963.00 | -539.00 | -3,493.00 | -3,018.00 |
Uses of Funds
1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | 1/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -304.00 | -229.00 | -75.00 | -337.00 | -339.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | -603.00 | 347.00 |
Increase (Decrease) Short-Term Debt | 1,010.00 | 1,321.00 | 500.00 | 5.00 | 2,909.00 |
Payment of Dividends & Other Distributions | -2,753.00 | -1,836.00 | -918.00 | -3,616.00 | -2,711.00 |
Other Financing Activities | -44.00 | 153.00 | -8.00 | -409.00 | -276.00 |
Net Cash from Financing Activities | -2,091.00 | -591.00 | -501.00 | -4,960.00 | -70.00 |
Effect of Exchange Rate Changes | -170.00 | -214.00 | -39.00 | 243.00 | 317.00 |
Net Change In Cash & Equivalents | 80.00 | -232.00 | -204.00 | -2,171.00 | 808.00 |
Cash at Beginning of Period | 1,543.00 | 1,543.00 | 1,543.00 | 3,714.00 | 3,714.00 |
Cash at End of Period | 1,623.00 | 1,311.00 | 1,339.00 | 1,543.00 | 4,521.00 |
Diluted Net EPS | 0.99 | 0.68 | 0.59 | 0.88 | 0.92 |